Gesellschaft bündeln Ankündigung alc 0315 lipid Retuschieren Skalk Lehm
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability - ScienceDirect
Structural characterization of the cationic lipid nanoparticle component, ALC-0315, and its impurities using electronactivated dissociation (EAD)-based MS/MS fragmentation
A Route to Synthesize Ionizable Lipid ALC-0315, a Key Component of the mRNA Vaccine Lipid Matrix | Russian Journal of Bioorganic Chemistry
In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy - ScienceDirect
ALC-0315 | Croda Pharma
Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells | Molecular Pharmaceutics
ALC-0315
Effect of mRNA-LNP components of two globally-marketed COVID-19 vaccines on efficacy and stability | npj Vaccines
CAS 2036272-55-4 Lipid ALC-0315 - BOC Sciences
Structural characterization of the cationic lipid nanoparticle component, ALC-0315, and its impurities using electronactivated dissociation (EAD)-based MS/MS fragmentation
A Route to Synthesize Ionizable Lipid ALC-0315, a Key Component of the mRNA Vaccine Lipid Matrix | Russian Journal of Bioorganic Chemistry
Real‐Time pH‐Dependent Self‐Assembly of Ionisable Lipids from COVID‐19 Vaccines and In Situ Nucleic Acid Complexation - Yu - 2023 - Angewandte Chemie International Edition - Wiley Online Library
Structure and Function of Cationic and Ionizable Lipids for Nucleic Acid Delivery | Pharmaceutical Research
A Route to Lipid ALC‐0315: a Key Component of a COVID‐19 mRNA Vaccine - Saadati - 2022 - Chemistry – A European Journal - Wiley Online Library